Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pharmacokinetic study of VX-150 capsule and tablet formulations with food, milk, and midazolam interaction in healthy adults
NL-OMON45544Phase 1Active, not recruiting
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jan 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of VX-150 in pain (8 arms), sponsored by Vertex Pharmaceuticals. Primary endpoint: Plasma PK parameter estimates of VRT-1207355 and M5. Started Jan 2017; status: active, not recruiting.
02
Drugs
VX-150
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON45544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45544.